Group bulletin

The CCTG Central Office will be closed on Monday, February 18, 2019 for Family Day. Regular business hours will resume on Tuesday, February 19, 2019 at 8:30 am EST.

Archived Bulletins

February 06, 2019

Published: February 06, 2019
Category: Trials

CCTG is pleased to announce that the CRC7 has met its accrual goal of 1180 patients and has been closed to accrual. CCTG CRC.7 (N1048) trial: A Phase II/III Trial of Neoadjuvant FOLFOX, with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision (PROSPECT)

Read More

Published: February 06, 2019
Category: Group updates
2019 Annual Spring Meeting
The 2019 CCTG Annual Spring Meeting of Participants will be here before you know it! Make sure that you save the date: May 3 - 5, Chelsea Hotel, Toronto.
 
The Canadian Cancer Trials Group Annual Spring Meeting of Participants represents a major gathering of the Canadian oncology community where trials that cover the spectrum of cancer treatment are designed and reviewed. Traditionally, the meeting includes discussions of trials that are in development, under conduct or have results to be shared.
 
Read More

Published: February 06, 2019
Category: News

The IND234 clinical trial, conducted by the Canadian Cancer Trials Group (CCTG), uses liquid biopsy technology to screen for genomic markers in prostate cancer patients.

After the liquid biopsy analysis, patients with specific DNA markers are assigned to one of five new therapies targeted at their unique form of prostate cancer. Researchers want to see if the markers identified in the screening process can help predict which patients will be helped the most by the targeted treatments.

Read More

Published: February 06, 2019
Category: Publications
 TAYLORx | CCTG MAC12

The New England Journal of Medicine Notable Articles of 2018 recognizes the significance of the TAYLORx | CCTG MAC12 study, in addition, the Journal of Clinical Oncology has also named TAILORx as one of the most important clinical research advances of 2018.

Read More

Published: February 06, 2019
Category: Publications

Citations for two previously published CCTG trials are now available online.

Read More

January 23, 2019

Published: January 23, 2019
Category: Trials

These CCTG trials have been formally permanently closed/terminated. No further ethics approvals or folow up data are required, more information can be found on the CCTG website under the "Toolbox".

Read More

Published: January 23, 2019
Category: Trials

CCTG trials BL13 and IND237 have been centrally activated with further information please visit the trial pages.

Read More

Published: January 23, 2019
Category: Trials

Trial-specific DSMC Summary Reports are now posted on trial websites. Single-study centres participating on these trials should download these reports and submit them to their Research Ethics Boards if required by local policy. Trials currently under CCTG's DSMC oversight include:

Read More